Biologics in Inflammatory Immune-mediated Systemic Diseases

被引：20
|
作者：
Moroncini, Gianluca [1 ]
Calogera, Giovanni [1 ]
Benfaremo, Devis [1 ]
Gabrielli, Armando [1 ]
机构：
[1] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Clin Med, Via Tronto 10-A, I-60126 Ancona, Italy
来源：
CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 2017年 / 18卷 / 12期
关键词：
ANCA-associated vasculitis; Behcet Disease; belimumab; rituximab; Systemic Lupus Erythematosus (SLE); Systemic Sclerosis (SSc); TNF-inhibitors; tocilizumab; RANDOMIZED CONTROLLED-TRIAL; ONSET STILLS-DISEASE; GIANT-CELL ARTERITIS; LOW-DOSE RITUXIMAB; ANTI-TNF AGENTS; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; BEHCETS-DISEASE; LUPUS-ERYTHEMATOSUS; MONOCLONAL-ANTIBODY;
D O I：
10.2174/1389201019666171226152448
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Background: The use of biologic agents in systemic immune-mediated diseases has dramatically increased in recent years, replacing conventional immunosuppressive strategies that are characterized by unspecific mechanisms of action and burdened with serious adverse effects. Biologic drugs have selective action towards specific targets, with considerable steroid-sparing effect. They are used nowadays to induce remission or treat specific organ involvements in systemic autoimmune diseases. Conclusion: In this review, we will discuss the scientific evidence supporting the use of biologics in these diseases, with a particular emphasis on their efficacy and safety profile compared to the conventional drugs.
引用
收藏
页码：1008 / 1016
页数：9
相关论文
共 50 条
  • [21] Vaccinations in patients with immune-mediated inflammatory diseases
    Rahier, Jean-Francois
    Moutschen, Michel
    Van Gompel, Alfons
    Van Ranst, Marc
    Louis, Edouard
    Segaert, Siegfried
    Masson, Pierre
    De Keyser, Filip
    RHEUMATOLOGY, 2010, 49 (10) : 1815 - 1827
  • [22] Chilblains in immune-mediated inflammatory diseases: a review
    Dubey, Shirish
    Joshi, Nilay
    Stevenson, Olivia
    Gordon, Caroline
    Reynolds, John A.
    RHEUMATOLOGY, 2022, 61 (12) : 4631 - 4642
  • [23] Acute Neurologic Manifestations of Systemic Immune-Mediated Diseases
    Galetta, Kristin
    Bhattacharyya, Shamik
    SEMINARS IN NEUROLOGY, 2021, 41 (05) : 541 - 553
  • [24] Fighting the "Lernaean Hydra" of systemic immune-mediated diseases
    Mavrogeni, Sophie I.
    Markousis-Mavrogenis, George
    Koutsogeorgopoulou, Loukia
    Kolovou, Genovefa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 280 : 133 - 134
  • [25] Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
    Shintaro Akiyama
    Soma Fukuda
    Joshua M Steinberg
    Hideo Suzuki
    Kiichiro Tsuchiya
    World Journal of Gastroenterology, 2022, 28 (25) : 2843 - 2853
  • [26] Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
    Akiyama, Shintaro
    Fukuda, Soma
    Steinberg, Joshua M.
    Suzuki, Hideo
    Tsuchiya, Kiichiro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (25) : 2843 - 2853
  • [27] Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases
    Balanescu, Andra-Rodica
    Bojinca, Violeta Claudia
    Bojinca, Mihai
    Donisan, Teodora
    Balanescu, Serban Mihai
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (02) : 1024 - 1029
  • [28] The immunoregulatory effects of scoparone on immune-mediated inflammatory diseases
    Qiu, Feifei
    Lin, Jingru
    Huang, Xiaofei
    Yang, Bin
    Lu, Weihui
    Dai, Zhenhua
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [29] Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison
    Maier, Jeanette A.
    Castiglioni, Sara
    Petrelli, Alessandra
    Cannatelli, Rosanna
    Ferretti, Francesca
    Pellegrino, Greta
    Puttini, Piercarlo Sarzi
    Fiorina, Paolo
    Ardizzone, Sandro
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [30] Immune-mediated Pathogenesis and Therapies for Inflammatory Autoimmune Diseases
    Islam, Md. Asiful
    Kamal, Mohammad A.
    Zulfiker, Abu H. Md
    Gan, Siew H.
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (27) : 2907 - 2908
12345